Prevention of peritoneal adhesions with an in situ cross-linkable hyaluronan hydrogel delivering budesonide

Journal of Controlled Release

Volumn 120, Issue 3, 2007, Pages 178-185

  Yeo, Yoon ^a   Adil, Maroof ^a   Bellas, Evangelia ^a   Astashkina, Anna ^a   Chaudhary, Nilika ^a   Kohane, Daniel S ^a,b  

^a Massachusetts Institute of Technology Cambridge   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Budesonide; Drug delivery; Hyaluronan hydrogel; Peritoneal adhesion; Repeated injury

Indexed keywords

BUDESONIDE; HYALURONAN HYDROGELS; PERITONEAL ADHESION; REPEATED INJURY;

BIOCOMPATIBILITY; CROSSLINKING; DRUG DELIVERY; HYDROGELS; MATHEMATICAL MODELS; TISSUE ENGINEERING;

DRUG PRODUCTS;

BUDESONIDE; HYALURONIC ACID;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG MECHANISM; DRUG RELEASE; HYDROGEL; MALE; NONHUMAN; PERITONEUM ADHESION; PRIORITY JOURNAL; RAT;

ANIMALS; ANTI-INFLAMMATORY AGENTS; BUDESONIDE; CROSS-LINKING REAGENTS; DRUG DELIVERY SYSTEMS; FEMALE; HYALURONIC ACID; HYDROGEL; MALE; MICROSCOPY, ELECTRON, SCANNING; PERITONEAL DISEASES; PERITONEUM; POSTOPERATIVE COMPLICATIONS; RABBITS; RATS; RATS, SPRAGUE-DAWLEY; SODIUM CHLORIDE; SOLUBILITY; TREATMENT OUTCOME;

EID: 34447503641     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jconrel.2007.04.016     Document Type: Article

References (40)

1. diZerega G.S. Peritoneum, peritoneal healing, and adhesion formation. In: diZerega G.S. (Ed). Peritoneal Surgery (2000), Springer, New York 3-37
2. Kucukozkan T., Ersoy B., Uygur D., and Gundogdu C. Prevention of adhesions by sodium chromoglycate, dexamethasone, saline and aprotinin after pelvic surgery. ANZ J. Surg. 74 (2004) 1111-1115
3. Hockel M., Ott S., Siemann U., and Kissel T. Prevention of peritoneal adhesions in the rat with sustained intraperitoneal dexamethasone delivered by a novel therapeutic system. Ann. Chir. Gynaecol. 76 (1987) 306-313
4. Buckenmaier C.C., Pusateri A.E., Harris R.A., and Hetz S.P. Comparison of antiadhesive treatments using an objective rat model. Am. Surgeon 65 (1999) 274-282
5. Maurer J., and Bonaventura L. The effect of aqueous progesterone on operative adhesion formation. Fertil. Steril. 39 (1983) 485-489
6. Gazzaniga A., James J., Shobe J., and Oppenheim E. Prevention of peritoneal adhesions in the rat. The effects of dexamethasone, methylprednisolone, promethazine, and human fibrinolysin. Arch. Surg. 110 (1975) 429-432
7. Jansen R. Failure of intraperitoneal adjuncts to improve the outcome of pelvic operations in young women. Am. J. Obstet. Gynecol. 153 (1985) 363-371
8. Larsson B. Prevention of postoperative formation and reformation of pelvic adhesions. In: Treutner K.H., and Schumpelick V. (Eds). Peritoneal Adhesions (1997), Springer-Verlag Telos, Berlin 331-334
9. Sekiba K. Use of Interceed(TC7) absorbable adhesion barrier to reduce postoperative adhesion reformation in infertility and endometriosis surgery. The Obstetrics and Gynecology Adhesion Prevention Committee. Obstet. Gynecol. 79 (1992) 518-522
10. Prevention of postsurgical adhesions by INTERCEED(TC7), an absorbable adhesion barrier: a prospective randomized multicenter clinical study. INTERCEED(TC7) Adhesion Barrier Study Group. Fertil. Steril. 51 (1989) 933-938
11. Becker J., Dayton M., Fazio V., Beck D., Stryker S., Wexner S., Wolff B., Roberts P., Smith L., Sweeney S., and Moore M. Prevention of postoperative abdominal adhesions by a sodium hyaluronate-based bioresorbable membrane: a prospective, randomized, double-blind multicenter study. J. Am. Coll. Surg. 183 (1996) 297-306
12. Diamond M. Reduction of adhesions after uterine myomectomy by Seprafilm membrane (HAL-F): a blinded, prospective, randomized, multicenter clinical study. Seprafilm Adhesion Study Group. Fertil. Steril. 66 (1996) 904-910
13. Vrijland W., Tseng L., Eijkman H., Hop W., Jakimowicz J., Leguit P., Stassen L., Swank D., Haverlag R., Bonjer H., and Jeekel H. Fewer intraperitoneal adhesions with use of hyaluronic acid-carboxymethylcellulose membrane: a randomized clinical trial. Ann. Surg. 235 (2002) 193-199
14. di Zerega G.S., Verco S.J.S., Young P., Kettel M., Kobak W., Martin D., Sanfilippo J., Peers E.M., Scrimgeour A., and Brown C.B. A randomized, controlled pilot study of the safety and efficacy of 4% icodextrin solution in the reduction of adhesions following laparoscopic gynaecological surgery. Hum. Reprod. 17 (2002) 1031-1038
15. Menzies D., Pascual M.H., Walz M.K., Duron J.J., Tonelli F., Crowe A., and Knight A. Use of icodextrin 4% solution in the prevention of adhesion formation following general surgery: from the multicentre ARIEL Registry. Ann. R. Coll. Surg. Engl. 88 (2006) 375-382
16. Lamoutte H., and Chatterji R. SurgiWrap(R) Mast bioresorbable sheet use for the prevention of soft tissue attachment; a two year experience, Biomaterials / Bioresorbable Technology, Mast Biosurgery (2005)
17. Hubbell J.A. Hydrogel systems for barriers and local drug delivery in the control of wound healing. J. Control. Release 39 (1996) 305-313
18. Reid R.L., Lie K., Spence J.E., Tulandi T., and Yuzpe A. Clinical evaluation of the efficacy of heparin-saturated interceed for prevention of adhesion reformation in the pelvic sidewall of the human. In: Diamond M.P., diZerega G.S., Linsky C.B., and Reid R.L. (Eds). Gynecologic Surgery and Adhesion Prevention (1993), Wiley-Liss, Inc., New York 261-264
19. Hill-West J.L., Dunn R.C., and Hubbell J.A. Local release of fibrinolytic agents for adhesion prevention. J. Surg. Res. 59 (1995) 759-763
20. Chowdhury S.M., and Hubbell J.A. Adhesion prevention with ancrod release via a tissue-adherent hydrogel. J. Surg. Res. 61 (1996) 58-64
21. Physicians' Desk Reference. 61th ed. (2007), Thomson PDR, Montvale, NJ
22. Yeo Y., Highley C.B., Bellas E., Ito T., Marini R., Langer R., and Kohane D.S. In situ cross-linkable hyaluronic acid hydrogels prevent post-operative abdominal adhesions in a rabbit model. Biomaterials 27 (2006) 4698-4705
23. Yeo Y., Ito T., Bellas E., Highley C.B., Marini R., and Kohane D.S. In situ cross-linkable hyaluronan hydrogels containing polymeric nanoparticles for preventing postsurgical adhesions. Ann. Surg. 245 (2007) 819-824
24. Bulpitt P., and Aeschlimann D. New strategy for chemical modification of hyaluronic acid: preparation of functionalized derivatives and their use in the formation of novel biocompatible hydrogels. J. Biomed. Mater. Res. 47 (1999) 152-169
25. Jia X., Colombo G., Padera R., Langer R., and Kohane D.S. Prolongation of sciatic nerve blockade by in situ cross-linked hyaluronic acid. Biomaterials 25 (2004) 4797-4804
26. Luo Y., Kirker K.R., and Prestwich G.D. Cross-linked hyaluronic acid hydrogel films: new biomaterials for drug delivery. J. Control. Release 69 (2000) 169-184
27. Gennaro A.R. Remington: The Science and Practice of Pharmacy. 20th ed., (2000), Lippincott Williams & Wilkins, Philadelphia, PA
28. Y. Yeo, E. Bellas, C.B. Highley, R. Langer, D.S. Kohane, Peritoneal adhesion prevention with an in situ cross-linkable hyaluronan gel containing tissue-type plasminogen activator in a rabbit repeated injury model, Biomaterials (in press), doi:10.1016/j.biomaterials.2007.04.033.
29. Burns J.W., Skinner K., Colt J., Sheidlin A., Bronson R., Yaacobi Y., and Goldberg E.P. Prevention of tissue injury and postsurgical adhesions by precoating tissues with hyaluronic acid solutions. J. Surg. Res. 59 (1995) 644-652
30. Jia X., Burdick J.A., Kobler J., Clifton R.J., Rosowski J.J., Zeitels S.M., and Langer R. Synthesis and characterization of in situ cross-linkable hyaluronic acid-based hydrogels with potential application for vocal fold regeneration. Macromolecules 37 (2004) 3239-3248
31. Yeo Y., Burdick J.A., Highley C.B., Marini R., Langer R., and Kohane D.S. Peritoneal application of chitosan and UV-cross-linkable chitosan. J. Biomed. Mater. Res. 78A (2006) 668-675
32. The United States Pharmacopeia (USP 30). The National Formulary (NF 25) (2007), The United States Pharmacopeial Convention, Rockville, MD 9
33. LaVan D.A., Padera R.F., Friedmann T.A., Sullivan J.P., Langer R., and Kohane D.S. In vivo evaluation of tetrahedral amorphous carbon. Biomaterials 26 (2005) 465
34. Kohane D.S., Tse J.Y., Yeo Y., Padera R., Shubina M., and Langer R. Biodegradable polymeric microspheres and nanospheres for drug delivery in the peritoneum. J. Biomed. Mater. Res. 77A (2006) 351-361
35. Thompson J. Peritoneal fibrinolysis and adhesion formation. In: diZerega G.S. (Ed). Peritoneal Surgery (2000), Springer, New York 133-142
36. Orita H., Fukasawa M., Girgis W., and diZerega G.S. Inhibition of postsurgical adhesions in a standardized rabbit model: intraperitoneal treatment with tissue plasminogen activator. Int. J. Fertil. 36 (1991) 172-177
37. Dunn R.C., and Mohler M. Effect of varying days of tissue plasminogen activator therapy on the prevention of postsurgical adhesions in a rabbit model. J. Surg. Res. 54 (1993) 242-245
38. Harris E., Morgan R., and Rodeheaver G. Analysis of the kinetics of peritoneal adhesion formation in the rat and evaluation of potential antiadhesive agents. Surgery 117 (1995) 663-669
39. Kohane D.S., Lipp M., Kinney R.C., Anthony D.C., Louis D.N., Lotan N., and Langer R. Biocompatibility of lipid-protein-sugar particles containing bupivacaine in the epineurium. J. Biomed. Mater. Res. 59 (2002) 450-459
40. Wiseman D.M. Animal adhesion models: design, variables, and relevance. In: diZerega G.S. (Ed). Peritoneal Surgery (2000), Springer, New York 459-476